126 related articles for article (PubMed ID: 14679008)
1. Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.
Cummings J; Ethell BT; Jardine L; Boyd G; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
Cancer Res; 2003 Dec; 63(23):8443-50. PubMed ID: 14679008
[TBL] [Abstract][Full Text] [Related]
2. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
Cummings J; Ethell BT; Jardine L; Burchell B
Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585
[TBL] [Abstract][Full Text] [Related]
3. Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation.
Cummings J; Boyd G; Ethell BT; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
Biochem Pharmacol; 2002 Feb; 63(4):607-13. PubMed ID: 11992628
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.
Cummings J; Zelcer N; Allen JD; Yao D; Boyd G; Maliepaard M; Friedberg TH; Smyth JF; Jodrell DI
Biochem Pharmacol; 2004 Jan; 67(1):31-9. PubMed ID: 14667926
[TBL] [Abstract][Full Text] [Related]
5. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
7. UDP-glucuronosyltransferase 1A6 is the major isozyme responsible for protocatechuic aldehyde glucuronidation in human liver microsomes.
Liu HX; Liu Y; Zhang JW; Li W; Liu HT; Yang L
Drug Metab Dispos; 2008 Aug; 36(8):1562-9. PubMed ID: 18474676
[TBL] [Abstract][Full Text] [Related]
8. UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers.
Oguri T; Takahashi T; Miyazaki M; Isobe T; Kohno N; Mackenzie PI; Fujiwara Y
Anticancer Res; 2004; 24(5A):2893-6. PubMed ID: 15517893
[TBL] [Abstract][Full Text] [Related]
9. Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential.
Wang Q; Hao H; Zhu X; Yu G; Lai L; Liu Y; Wang Y; Jiang S; Wang G
Drug Metab Dispos; 2010 Jul; 38(7):1132-40. PubMed ID: 20382756
[TBL] [Abstract][Full Text] [Related]
10. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.
Brangi M; Litman T; Ciotti M; Nishiyama K; Kohlhagen G; Takimoto C; Robey R; Pommier Y; Fojo T; Bates SE
Cancer Res; 1999 Dec; 59(23):5938-46. PubMed ID: 10606239
[TBL] [Abstract][Full Text] [Related]
11. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
[TBL] [Abstract][Full Text] [Related]
12. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
Al-Zoughool M; Talaska G
J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
[TBL] [Abstract][Full Text] [Related]
13. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
Sun H; Ma Z; Lu D; Wu B
J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
[TBL] [Abstract][Full Text] [Related]
14. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
Margaillan G; Rouleau M; Fallon JK; Caron P; Villeneuve L; Turcotte V; Smith PC; Joy MS; Guillemette C
Drug Metab Dispos; 2015 Apr; 43(4):611-9. PubMed ID: 25650382
[TBL] [Abstract][Full Text] [Related]
15. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
16. UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells.
Liu M; Wang Q; Liu F; Cheng X; Wu X; Wang H; Wu M; Ma Y; Wang G; Hao H
PLoS One; 2013; 8(11):e79172. PubMed ID: 24244442
[TBL] [Abstract][Full Text] [Related]
17. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
Aprile S; Del Grosso E; Grosa G
Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the major metabolite of the novel topoisomerase I inhibitor NU/ICRF 505.
Cummings J; Meikle I; Macpherson JS; Smyth JF
Anticancer Drug Des; 1996 Jul; 11(5):367-82. PubMed ID: 8765530
[TBL] [Abstract][Full Text] [Related]
19. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; RamÃrez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
